The companies have entered into a clinical trial collaboration to evaluate Compugen’s COM701 with BMS's PD-1 immune checkpoint inhibitor Opdivo, in patients with advanced solid tumors.


00


Globes

Latest News

WashingtonPost: Trump’s safety panel recommends schools consider arming personnel

WashingtonPost: At Olive Garden’s Parent, Wage Costs Crash the Party

NewYorkTimes: Kashmiri Teenagers Are Dying to Protect Militants

USA Today: Congressman says migrant woman tear-gassed with kids in viral photo applies for asylum

NewYorkTimes: Lebanese-born Architect Chosen for Beirut Museum of Art

NewYorkTimes: Show Us Your Wall: His Passion Emerges Annually. He Hangs It on a Tree. Or Three.

NewYorkTimes: At ‘The Prom’ on Broadway, It’s Time to Dance (and Flip)

FOX: Visually impaired Michigan woman missing in Peru, family says

FOX: Utah's new DUI law, strictest in the nation, set to be implemented ahead of New Year's Eve

FOX: Visually impaired Michigan woman missing in Peru, family says

CNN: Here's the little secret of Mick Mulvaney's flip-flop on Donald Trump

CNN: Putin's war on rap unites Russia's hip hop artists

Daily Mail: Christmas is CANCELLED in a Chinese city as local government bans festive decoration

Daily Mail: Scotland Yard spent more than £8k on post-mortems for pets over Croydon Cat Killer

BBC: Christina Abbotts: Murder accused 'blames red mist'

Daily Mail: Christmas is CANCELLED in a Chinese city as local government bans festive decoration

Daily Mail: Scotland Yard spent more than £8k on post-mortems for pets over Croydon Cat Killer

BBC: Tottenham fan fined and banned for throwing banana skin at Arsenal

BBC: Prime targets and long shots: Who will be the next Man Utd manager?

ABC: Ronan and Robbie didn't rehearse together for 'Mary, Queen of Scots'

CNBC: People in these US counties are at risk of dying early

CNBC: Suze Orman: Here's how much money you should be saving for retirement

Reuters: UPDATE 1-Musk's SpaceX to raise $500 mln in funding - WSJ

18 Related Articles from 2018-10-11